Company Encyclopedia
View More
name
NovelBeam Technology
688677.SH
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and optical devices and components, including dental endoscopes, light source modules for microscopes and PCR analysis, fluorescence filters, beauty machine filters, light sheets, and high-energy laser scanning mirror, etc. It also provides optical imaging solutions for clinical medicine; and identity information management solutions based on biometrics.
900.37 B
688677.SHMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking18/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE13.41%B
    • Profit Margin30.49%A
    • Gross Margin70.35%A
  • Growth ScoreA
    • Revenue YoY38.44%A
    • Net Profit YoY39.56%B
    • Total Assets YoY14.67%A
    • Net Assets YoY2.84%C
  • Cash ScoreB
    • Cash Flow Margin327.99%C
    • OCF YoY38.44%A
  • Operating ScoreC
    • Turnover0.38C
  • Debt ScoreA
    • Gearing Ratio17.71%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    NovelBeam Technology: As of the end of October, a total of 50.0134 million yuan worth of shares have been repurchased

    NovelBeam Technology announced that the company agreed to repurchase shares using its own and loan funds ranging from 50 million to 100 million yuan through centralized bidding on March 3, 2025, for employee stock ownership or equity incentives, with a repurchase price not exceeding 59 yuan per share, and the period lasting until March 2, 2026. As of October 31, a total of 1.3876 million shares have been repurchased, accounting for 1.1575% of the total share capital, with a total payment of 50.0134 million yuan, and the repurchase price ranging from 28.53 yuan per share to 51.95 yuan per share

    Zhitong·
    SH
    688677
    -2.14%
    Zhitong·
    SH
    688677
    -2.14%

    NovelBeam Technology: Net profit in the first three quarters increased by 40.03% year-on-year

    On October 24th, NovelBeam Technology released its Q3 2025 report, showing that the company's third-quarter operating revenue was 182 million yuan, a year-on-year increase of 85.26%; net profit was 61.9307 million yuan, a year-on-year increase of 130.72%. For the first three quarters, operating revenue was 448 million yuan, a year-on-year increase of 40.47%; net profit was 136 million yuan, a year-on-year increase of 40.03%; basic earnings per share were 1.14 yuan

    Zhitong·
    SH
    688677
    -2.14%
    Zhitong·
    SH
    688677
    -2.14%

    NovelBeam Technology: The controlling shareholder plans to reduce its holdings by no more than 2.7345% of the company's shares

    NovelBeam Technology announced that the controlling shareholder Mr. ZHENGANMIN intends to reduce his holdings by no more than 3.278 million shares, accounting for no more than 2.7345% of the company's total share capital. The reduction period is within 3 months after 15 trading days from the announcement date, and the reason for the reduction is personal funding needs. This reduction will not lead to changes in the company's controlling shareholder or actual controller, nor will it have a significant impact on the company's ongoing stable operations

    Zhitong·
    SH
    688677
    -2.14%
    Zhitong·
    SH
    688677
    -2.14%

    The concerted actor of the actual controller of NovelBeam Technology, Ma Min, intends to reduce holdings by no more than 252,000 shares

    According to the Zhitong Finance APP, NovelBeam Technology announced that Ms. Ma Min, a concerted actor of the actual controller, plans to reduce her shareholding by no more than 252,000 shares, accounting for no more than 0.2102% of the company's total share capital

    Zhitong·
    SH
    688677
    -2.14%
    Zhitong·
    SH
    688677
    -2.14%

    NovelBeam Technology: Shareholder's reduction plan deadline has passed without any reduction

    NovelBeam Technology announced that shareholders Pu Aoda, Jialeite, and Ma Min plan to reduce their holdings by no more than 1.2061 million shares, shareholder Zheng Jinlan plans to reduce by no more than 21,000 shares, and shareholder Wang Fanghua plans to reduce by no more than 54,500 shares. As of May 26, 2025, the reduction period expires, and all shareholders have not reduced their holdings in the company

    Zhitong·
    SH
    688677
    -2.14%
    Zhitong·
    SH
    688677
    -2.14%